เกจวัดแรงดันไทวัสดุ has entered right into a definitive agreement to accumulate Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and control devices for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s products will expand Dover’s biopharma single-use manufacturing providing, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with services in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in revenue during the full 12 months 2022.
When the deal closes, Malema will turn out to be a half of the PSG enterprise unit inside Dover’s Pumps & Process Solutions segment.
“We see an amazing long-term progress opportunity in the bioprocessing trade pushed by a strong and growing pipeline of efficient novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more efficient single-use manufacturing processes supports a strong outlook for our offerings of single-use parts to end-customers. We imagine that pairing Malema’s know-how with our current portfolio of single-use pumps for biopharma processing will significantly improve the accuracy and value proposition of our options to our customers.”
“We are methodically building out our biopharma platform via proactive capacity additions, new product growth, and opportunistic acquisitions of highly-attractive niche element technologies,” mentioned Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing technology and further strengthens our sensor portfolio with new proprietary know-how. In addition to engaging biopharma purposes, we expect strong progress in the semiconductor area on the capability growth and re-shoring tailwinds.”
Share